Latest GlaxoSmithKline News

FILE - In this July 2, 2020 file photo, nurse Nomautanda Siduna, right, talks to a patient who is HIV-positive inside a gazebo used as a mobile clinic in Ngodwana, South Africa. Researchers are stopping a study early after finding that a shot of an experimental medicine every two months worked better than daily Truvada pills to help keep uninfected women from catching HIV from an infected sex partner.  The news is a boon for AIDS prevention efforts especially in Africa, where the study took place, and where women have few discreet ways of protecting themselves from infection.  (AP Photo/Bram Janssen, File)

Study finds long-acting shot helps women avoid HIV infection

Nov. 9, 2020 12:00 PM EST

Researchers are stopping a study early after finding that a shot of an experimental medicine every two months worked better than daily pills to help keep women from catching HIV from an infected sex partner. The news is a boon for AIDS prevention efforts especially in Africa, where the study took place, and...

GSK says Q3 earnings fall 14.4% amid COVID-19 disruption

Oct. 28, 2020 8:53 AM EDT

LONDON (AP) — Drugmaker GlaxoSmithKline says third-quarter earnings fell 14.4% as disruptions caused by the COVID-19 pandemic reduced sales of vaccines, antibiotics and consumer healthcare products. The company said Wednesday that pretax profit dropped to 1.67 billion pounds ($2.16 billion) from 1.95...

Sanofi, GSK to provide COVID-19 vaccine to global alliance

Oct. 28, 2020 3:50 AM EDT

LONDON (AP) — Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX Facility, a collaboration designed to give countries around the world equal access to coronavirus vaccines. The Sanofi-GSK vaccine candidate is in early stage...

Pfizer signs are seen out front of the Pfizer Research & Development Laboratories Wednesday, July 22, 2020, in Groton, Conn.  Pfizer on Tuesday, July 28,  reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of and new prescriptions for its medicines. Still, the biggest U.S. drugmaker posted a solid profit and nudged up parts of its 2020 financial forecast. (AP Photo/Stew Milne)

Pfizer tops 3Q earnings views, makes progress on COVID shot

Oct. 27, 2020 5:12 PM EDT

Drugmaker Pfizer, one of the leaders in the race to develop a COVID-19 vaccine, is tweaking its timeline for when it will know if its experimental two-dose vaccine works. Pfizer executives had expected data from their 44,000-person international study would show by Oct. 31 how well it prevents coronavirus...

In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. (Regeneron via AP)

Antibody drugs are no cure but seem promising for COVID-19

Oct. 8, 2020 1:08 PM EDT

WASHINGTON (AP) — They’re not cures and it’s not likely that everyone will be able to get them as President Donald Trump has suggested. But experimental antibody drugs like the one Trump was given are among the most promising therapies being tested for treating and preventing coronavirus...

FILE - In this Tuesday, May 30, 2017 file photo, Nvidia CEO Jensen Huang delivers a speech about AI and gaming during the Computex Taipei exhibition at the world trade center in Taipei, Taiwan. Graphics chip maker Nvidia said Monday, Oct. 5, 2020 it plans to build Britain's fastest supercomputer that healthcare researchers can use to work on medical problems including COVID-19. Santa Clara, California-based Nvidia said it will spend 40 million pounds ($52 million) on the supercomputer, dubbed Cambridge-1, which will consist of 80 Nvidia systems and is expected to be online by the end of the year. (AP Photo/Chiang Ying-ying, File)

Nvidia says it will build UK's most powerful supercomputer

Oct. 5, 2020 11:45 AM EDT

LONDON (AP) — Graphics chip maker Nvidia said Monday it plans to build Britain's fastest supercomputer that healthcare researchers can use to work on medical problems including COVID-19. Nvidia, based in Santa Clara, California, said it will spend 40 million pounds ($52 million) on the supercomputer,...